The Schmidt Firm, LLP

  • Home
  • Practice Areas
    • Accidents & Personal Injury
    • Business & Contract Litigation
    • Class Action
    • Diseases
    • Fair Debt Collection Act Lawyer
    • Food Poisoning
    • Malpractice
    • Medical Devices
    • Oil & Gas Litigation
    • Prescription and Over-the-Counter Drugs
    • Product Liability
    • Sexual Abuse
    • Toxic Substances
  • About Us
  • Meet the Attorneys
  • Firm News
  • Attorney Referrals
  • Contact Us

New York Times: Contaminated Avastin Causing Blindness


Tweet
|
Contaminated Avastin Causing Blindness

New York Times: Five veterans in Los Angeles were blinded after receiving Avastin to treat eye disease, prompting an investigation by the Department of Veterans Affairs. To date, at least 21 patients have suffered eye infection or blindness after being injected with Avastin.

In a September 1, 2011 article, the New York Times reported five veterans were blinded after undergoing Avastin eye disease treatment for “wet” macular degeneration at the Los Angeles Veterans Affairs medical center.

All five patients received their injections on August 12, 2011 at the Veterans Affairs Sepulveda Ambulatory Care Center in the San Fernando Valley. However, the patients reportedly learned the drug came from the pharmacy at the Veterans Affairs main campus in Los Angeles.

One patient told the New York Times:

“We all ended up in the E.R. over the course of the next few days and put together the connection.”

In addition, 4 patients at a Nashville Veterans Affairs hospital suffered infection after receiving a bacterially contaminated Avastin treatment. And the FDA has received 12 additional reports of eye infection in patients who received Avastin treatment in Miami, Florida. Some of these patients lost all remaining vision in the treated eye due to the infection, called Streptococcus endophthalmitis.

Avastin, manufactured by Genentech, is FDA approved for treatment of various types of cancers. Doctors also prescribe it for macular degeneration, a condition usually affecting older adults, where damage to the retina causes a loss of vision in the center of the visual field. The “wet” form of this condition is caused when abnormal blood vessels grow behind the retina, causing the vision loss. Avastin treats “wet” macular degeneration by blocking a protein from stimulating new blood vessel growth. Avastin is not FDA approved for this kind of treatment.

However, doctors prescribe the Avastin injections because they cost approximately $50 each. In comparison to the $2,000 FDA-approved Lucentis injections, Avastin is much cheaper and saves patients money.

Approximately 30-40 patients receive eye disease injections per week from Veterans Affairs in Los Angeles. Veterans Affairs has temporarily suspended Avastin injections and replaced them with the more expensive Lucentis injections.

Avastin eye disease dosages are created by dividing up larger doses of the drug. A vial meant for cancer treatment is divided into tiny doses, which are placed into a syringe to be injected into the eye. It could be this extra handling that causes bacterial contamination of the injections, leading to the infection.

The Miami infections were traced back to tainted injections distributed by a pharmacy in Hollywood, Florida. The pharmacy repackaged larger doses of sterilized Avastin injections into individual 1 mL single-use syringes. These syringes were then distributed to multiple eye clinics. To date, the FDA has traced eye infections to at least three of these clinics.

The FDA warns the syringes may not have been properly sterilized, leading to the infections:

“Health care professionals should be aware that repackaging sterile drugs withough proper aseptic technique can compromise product sterility, potentially putting the patient at risk for microbial infections. Health care professionals should ensure that drug products are obtained from appropriate, reliable sources and properly administered.”

Do I Have an Avastin Lawsuit?

The Schmidt Firm, LLP is currently accepting Avastin induced injury cases in all 50 states. If you or somebody you know has been injured by Avastin, you should contact our firm immediately for a free case consultation. Please use the form below to contact our Dangerous Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us your case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Related Posts

  • Avastin Shows Promise for HER-2 Positive Breast Cancer
  • FDA Revokes Avastin Breast Cancer Approval
  • Avastin Lawsuits
  • Avastin Warning Label to Include Risks of Blood Clot, Ovarian Failure and Jaw Deterioration

Free Case Evaluation

The Schmidt Firm, LLP has been recognized as one of the nation's leading plaintiff's law firms and handles cases in all 50 states. We are very proud of our legal achivements, but equally self-respecting of our firms reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.


Search the Site


Below is a partial list of the awards and recognition that the attorneys / lawyers at our law firm have been awarded with, as well as a list of professional memberships.

Contact Us With Confidence

AV® Peer Review Rated Law Firm - An AV® certification mark is a significant rating accomplishment - a testament to the fact that a lawyer's peers rank him or her at the highest level of professional excellence. A lawyer must be admitted to the bar for 10 years or more to receive an AV® rating.



  • Million Dollar Advocates Forum
  • Super Lawyers
  • Best Lawyers in America
  • Lawdragon Top 500 Leading
    Lawyers in America
  • "Presidents Club"
  • American Association for Justice
  • American Bar Association
  • American Board of Trial Advocates
  • American College of Trial Lawyers
  • International Academy of
    Trial Lawyers
  • International Society of Barristers

  • Sitemap
Copyright ©2012 The Schmidt Firm, LLP. All Rights Reserved.
The Schmidt Firm, LLP | 3012 Fairmount Street | Dallas, Texas 75201 | (866) 920-0753